Source Natural Foods and Herbal Supplements Limited (SOURCENTRL.BO)
INR 206.05
(-5.89%)
INR 206.05
(-5.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 41.97 Million INR | 5.63% |
| 2022 | 39.73 Million INR | 6.59% |
| 2021 | 37.27 Million INR | -8.19% |
| 2020 | 40.6 Million INR | 21.28% |
| 2019 | 33.47 Million INR | 66.84% |
| 2018 | 20.06 Million INR | -39.85% |
| 2017 | 33.35 Million INR | -26.75% |
| 2016 | 45.53 Million INR | 330.1% |
| 2015 | 10.58 Million INR | 22.11% |
| 2014 | 8.67 Million INR | 91.52% |
| 2013 | 4.52 Million INR | -82.27% |
| 2012 | 25.52 Million INR | 5.81% |
| 2011 | 24.12 Million INR | 83.22% |
| 2010 | 13.16 Million INR | 60.83% |
| 2009 | 8.18 Million INR | -73.17% |
| 2008 | 30.52 Million INR | 2.34% |
| 2007 | 29.82 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 41.97 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 41.97 Million INR | 5.63% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 47.8 Million INR | 0.0% |
| 2022 Q4 | 39.73 Million INR | 0.0% |
| 2022 Q2 | 35.51 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 39.73 Million INR | 6.59% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 37.27 Million INR | -8.19% |
| 2021 Q4 | 37.27 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 48.91 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 36.15 Million INR | 0.0% |
| 2020 FY | 40.6 Million INR | 21.28% |
| 2020 Q4 | 40.6 Million INR | 0.0% |
| 2019 Q2 | 31.62 Million INR | 0.0% |
| 2019 FY | 33.47 Million INR | 66.84% |
| 2019 Q4 | 33.47 Million INR | 0.0% |
| 2018 Q4 | 20.06 Million INR | 0.0% |
| 2018 Q2 | 38.46 Million INR | 0.0% |
| 2018 FY | 20.06 Million INR | -39.85% |
| 2017 Q2 | 41.59 Million INR | 0.0% |
| 2017 FY | 33.35 Million INR | -26.75% |
| 2017 Q4 | 33.35 Million INR | 0.0% |
| 2016 Q2 | 14.03 Million INR | 0.0% |
| 2016 FY | 45.53 Million INR | 330.1% |
| 2016 Q4 | 45.53 Million INR | 0.0% |
| 2015 FY | 10.58 Million INR | 22.11% |
| 2015 Q2 | 14.5 Million INR | 0.0% |
| 2015 Q4 | 10.58 Million INR | 0.0% |
| 2014 Q4 | 8.67 Million INR | 0.0% |
| 2014 FY | 8.67 Million INR | 91.52% |
| 2014 Q2 | 10.88 Million INR | 0.0% |
| 2013 Q2 | 29.02 Million INR | 0.0% |
| 2013 Q4 | 4.52 Million INR | 0.0% |
| 2013 FY | 4.52 Million INR | -82.27% |
| 2012 FY | 25.52 Million INR | 5.81% |
| 2012 Q4 | 25.52 Million INR | 0.0% |
| 2011 Q4 | 24.12 Million INR | 0.0% |
| 2011 FY | 24.12 Million INR | 83.22% |
| 2010 FY | 13.16 Million INR | 60.83% |
| 2009 FY | 8.18 Million INR | -73.17% |
| 2008 FY | 30.52 Million INR | 2.34% |
| 2007 FY | 29.82 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -63.308% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 95.787% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -99.962% |
| Vasundhara Rasayans Limited | 53.64 Million INR | 21.763% |
| Sunil Healthcare Limited | 902.83 Million INR | 95.351% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -1872.368% |
| MedPlus Health Services Limited | 14.27 Billion INR | 99.706% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 95.821% |
| Patidar Buildcon Limited | 25.57 Million INR | -64.133% |
| Roopa Industries Limited | 493.08 Million INR | 91.488% |
| Smruthi Organics Limited | 485.72 Million INR | 91.359% |
| Trident Lifeline Limited | 331.26 Million INR | 87.33% |
| PANJON LTD. | 25.38 Million INR | -65.355% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 79.864% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 74.039% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -180.206% |
| Anuh Pharma Limited | 1.54 Billion INR | 97.283% |
| Crestchem Limited | 23.94 Million INR | -75.27% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -213.107% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | 64.498% |
| Tyche Industries Limited | 101.64 Million INR | 58.706% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 97.745% |
| Trimurthi Limited | 101.36 Thousand INR | -41308.84% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 79.219% |
| Norris Medicines Limited | 278.17 Million INR | 84.912% |
| Zenlabs Ethica Limited | 301.35 Million INR | 86.072% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 85.6% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 97.474% |
| Parmax Pharma Limited | 117.56 Million INR | 64.3% |
| Veerhealth Care Limited | 62.78 Million INR | 33.144% |
| Deccan Health Care Limited | 111.33 Million INR | 62.302% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 97.551% |
| Makers Laboratories Limited | 569.18 Million INR | 92.626% |
| Lactose (India) Limited | 536.39 Million INR | 92.175% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 94.962% |
| Zenith Healthcare Limited | 24.03 Million INR | -74.629% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 72.933% |
| Bacil Pharma Limited | 1.12 Million INR | -3617.626% |
| PRAVEG LIMITED | 767.53 Million INR | 94.532% |
| Denis Chem Lab Limited | 289.82 Million INR | 85.518% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 97.554% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 79.18% |
| Colinz Laboratories Limited | 24.1 Million INR | -74.122% |
| Godavari Drugs Limited | 957.86 Million INR | 95.618% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -13937.458% |
| Zenotech Laboratories Limited | 156.64 Million INR | 73.206% |
| Panchsheel Organics Limited | 340.2 Million INR | 87.663% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 91.406% |
| Vivanza Biosciences Limited | 148.63 Million INR | 71.761% |
| Phaarmasia Limited | 211.49 Million INR | 80.155% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 97.203% |
| Medi-Caps Limited | 63.01 Million INR | 33.395% |
| DECIPHER LABS LIMITED | 117.72 Million INR | 64.347% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 78.735% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 96.289% |
| Mercury Laboratories Limited | 171.18 Million INR | 75.482% |
| Gennex Laboratories Limited | 535.21 Million INR | 92.158% |
| BDH Industries Limited | 312.53 Million INR | 86.57% |
| Coral Laboratories Limited | 281.83 Million INR | 85.108% |
| Concord Drugs Limited | 249.88 Million INR | 83.204% |
| Bharat Parenterals Limited | 2.65 Billion INR | 98.42% |
| Beryl Drugs Limited | 85.63 Million INR | 50.988% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 76.039% |
| Evoq Remedies Limited | 116.23 Million INR | 63.889% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 73.636% |
| Transchem Limited | 6.72 Million INR | -524.583% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -373.084% |
| Parnax Lab Limited | 1.17 Billion INR | 96.415% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 96.032% |
| Cian Healthcare Limited | 1.03 Billion INR | 95.942% |
| Trinity League India Limited | 876 Thousand INR | -4691.324% |
| Syschem (India) Limited | 1.07 Billion INR | 96.08% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 97.946% |
| Natural Capsules Limited | 1.47 Billion INR | 97.159% |
| Auro Laboratories Limited | 433.09 Million INR | 90.309% |